Simile Raises $200 Million Series B at $2 Billion Valuation
Simile raised a $200 million Series B at a $2 billion valuation. The round was led by Greenoaks Capital, with participation from Index Ventures, Hanabi Capital, Bain Capital Ventures, A*, Factory, CVS Health Ventures, and new investor Definition.
The company said the funding will support development of its foundation model for human behavior and help scale its simulation platform. The round follows a $100 million Series A led by Index Ventures five months ago, when Simile emerged from stealth.
Organizations including CVS Health and Wealthfront are using Simile to simulate human behavior and test decisions before using them in live settings. CVS Health has used the platform for customer research validation, patient satisfaction analysis, medication adherence planning, competitive benchmarking, and modeling patient groups that are hard to reach.
Simile is also working with Gallup on AI powered simulations for policy research, trend analysis, workplace studies, and social research. The company was founded by CEO Joon Sung Park.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Enterprise AI Brief or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer Bank Oct 16 KP Labs raises €4.42 million for AI data processing in orbit Oct 15 Origin Raises $20 Million for Autonomous Construction RobotsMore from Enterprise
Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 ALTOUR Unveils AI Platform for Corporate Travel Decisions Oct 16 BOC Group Adds AI Assistant to ADOIT 21 Oct 16 Huawei Brings Upgraded Stellar Network Solution to Europe Oct 16 Element to Manage Waymo's Toronto Fleet for 2028 LaunchEnterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Melius Raises $25 Million for AI Ad Creation Platform
Healthleap Raises $38 Million for Hospital Risk Screening AI
PaleBlueDot AI Raises $200 Million at $3.2 Billion Valuation
EliseAI raises $350 million at $4 billion valuation
Chamelio Raises $26 Million for Legal AI Platform
Daily AI Brief: the AI news that matters, in your inbox.